AMBONI, Marianna
 Distribuzione geografica
Continente #
NA - Nord America 4.620
EU - Europa 1.432
AS - Asia 774
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
SA - Sud America 1
Totale 6.834
Nazione #
US - Stati Uniti d'America 4.611
CN - Cina 435
UA - Ucraina 332
IT - Italia 326
DE - Germania 211
IE - Irlanda 190
TR - Turchia 167
SE - Svezia 142
VN - Vietnam 136
RU - Federazione Russa 83
FI - Finlandia 58
GB - Regno Unito 38
FR - Francia 23
IN - India 16
CZ - Repubblica Ceca 12
JP - Giappone 7
CA - Canada 6
BE - Belgio 5
EU - Europa 5
HK - Hong Kong 5
PL - Polonia 4
IL - Israele 3
AU - Australia 2
KR - Corea 2
MX - Messico 2
BR - Brasile 1
DK - Danimarca 1
HR - Croazia 1
IR - Iran 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
NL - Olanda 1
PA - Panama 1
RO - Romania 1
SG - Singapore 1
Totale 6.834
Città #
Ann Arbor 1.105
Princeton 518
Chandler 509
Wilmington 468
Jacksonville 429
Houston 247
Woodbridge 201
Dublin 187
Ashburn 176
Izmir 165
Dong Ket 136
Nanjing 112
Andover 104
Beijing 90
Boardman 85
Salerno 69
Pellezzano 64
Düsseldorf 55
Norwalk 53
Dearborn 44
Shenyang 43
Nanchang 39
Fairfield 34
Mestre 34
Naples 30
Hebei 29
Redwood City 26
Jiaxing 24
Changsha 19
Tianjin 18
Pune 16
Rome 15
San Diego 15
Washington 14
Milan 12
West Jordan 10
Cambridge 7
Santa Maria A Vico 7
Dormagen 6
Fuzhou 6
Hefei 6
Jinan 6
Napoli 6
Wuhan 6
Brussels 5
Fukushima 5
Guangzhou 5
Kunming 5
Los Angeles 5
Sant'arpino 5
Hangzhou 4
Seattle 4
Canzo 3
Caserta 3
Frankfurt am Main 3
New York 3
Orange 3
Ottawa 3
Zhengzhou 3
Assago 2
Brno 2
Casavatore 2
Casoria 2
College Park 2
Dallas 2
Eboli 2
Esslingen am Neckar 2
Falkenstein 2
Fucecchio 2
Hanover 2
Helsinki 2
Lappeenranta 2
Littleton 2
Newcastle upon Tyne 2
Nocera Inferiore 2
Seo-gu 2
Solna 2
Taizhou 2
Vitry-le-François 2
Wenzhou 2
Airdrie 1
Albany 1
Amsterdam 1
Angri 1
Assèmini 1
Atlanta 1
Bologna 1
Brugherio 1
Böblingen 1
Calgary 1
Castrovillari 1
Catanzaro 1
Chongqing 1
Clapham 1
Copenhagen 1
Edinburgh 1
Frattamaggiore 1
Gallarate 1
Gunzenhausen 1
Haikou 1
Totale 5.366
Nome #
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 120
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 116
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 103
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 101
Increased bilirubin levels in de novo Parkinson's disease 98
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 95
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 92
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 91
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 87
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 86
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 82
Gender and non motor fluctuations in Parkinson's disease: A prospective study 81
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 80
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 79
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 79
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 78
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 78
Quitting smoking: An early non-motor feature of Parkinson's disease? 77
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 77
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 77
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 76
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 75
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 74
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 73
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 72
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 71
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 71
Music Therapy for Motor and Nonmotor Symptoms of Parkinson's Disease: A Prospective, Randomized, Controlled, Single-Blinded Study 70
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 68
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 68
Uric acid relates to dopamine transporter availability in Parkinson's disease. 67
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 67
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 67
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 67
Abnormal eating behaviors in progressive supranuclear palsy. 66
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 66
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 65
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 64
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 64
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 63
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system 62
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 62
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 62
null 61
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 61
Bisphenol A glucuronidation in patients with Parkinson's disease 61
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 60
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 60
Parkinson’s disease and the spectrum of Lewy body disease 60
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 59
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease 58
The "eye of the tiger" sign in pure akinesia with gait freezing. 57
Cognitive contributions to gait and falls: Evidence and implications 57
Caratteristiche Cliniche 57
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 56
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 55
Ropinirole as a treatment of restless legs syndrome in patients on chronichemodialysis: an open randomized crossover trial versus levodopa sustainedrelease 55
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 55
Neuropsychological correlates of theory of mind in patients withearly Parkinson's disease. 55
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 55
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 55
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 55
Resting brain networks in patients with Parkinson's disease and freezing of gait 54
Hemi-restless legs syndrome induced by clebopride 54
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson’s disease 54
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 53
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 51
Freezing of gait and executive functions in patients with Parkinson's disease. 50
Exercise dependence induced by pramipexole in Parkinson's Disease-a case report. 49
Freezing of gait and executive functions in patients with Parkinson’s disease 49
Longitudinal Changes Of Dopamine Transporter In Early-Onset Parkin Disease Measured With 123Fr-Cit Spect 49
Comparative neuropsychological profile of pathological gambling, hypersexuality and compulsive eating in Parkinson’s disease. 48
Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients 47
Parkinsonism and essential tremor in a family with pseudo-dominant inheritance ofPARK2: an FP-CIT SPECT study 47
Mild cognitive impairment in drug-naive patients with PD is associated withcerebral hypometabolism 47
Future thinking in Parkinson's disease: An executive function? 47
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 47
Classifying Different Stages of Parkinson’s Disease Through Random Forests 47
Ropinirole as treatment of restless leg sindrome in patients on chrnic hemodyalisis: an open randomized, crossover trial versus levodopa sustained release 46
Neuropsychological Correlates Of Major Depressive Episode In Parkinson’s Diesease 45
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 45
Metabolomics in Parkinson's disease 45
Serum IGF-1 is associated with cognitive functions in early, drug-naive Parkinson's disease 44
Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy. 43
Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease 43
Gait patterns and cognition in Parkinson's disease 43
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 42
Development of software tool for quantitative gait assessment in Parkinsonian patients with and without Mild Cognitive Impairment 41
The use of smell identification test in Parkinson's disease in Italy: Preliminary data 41
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 41
Demenza nella malattia di Parkinson 40
Imaging of dopaminergic dysfunction with 123FP-CIT SPECT in eary-onset parkin disease 39
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 39
Neuropsychiatric disturbances in parkinsonian patients with and without freezing of gait 38
“Response to Apomorphine in early Parkinson’s disease”. 38
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 38
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 37
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 37
Future thinking in Parkinson's disease: The contribution of executive functions 33
Depression, Apathy, Anhedonia, and Fatigue in Parkinson’s Disease 33
Totale 6.113
Categoria #
all - tutte 23.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.347


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019295 0 0 0 0 0 0 0 0 0 0 268 27
2019/2020952 285 38 105 13 52 24 91 18 73 74 163 16
2020/2021722 3 55 62 0 107 60 83 6 68 3 95 180
2021/2022829 9 2 12 14 6 1 7 33 112 117 120 396
2022/20231.274 154 67 37 114 203 295 11 111 185 12 61 24
2023/2024533 44 105 40 42 29 90 25 63 35 57 3 0
Totale 7.202